Aziyo biologics to participate in the truist securities life sciences summit

Silver spring, md., april 26, 2021 (globe newswire) -- aziyo biologics, inc. (nasdaq: azyo), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced the company will participate in the upcoming truist securities life sciences summit.
AZYO Ratings Summary
AZYO Quant Ranking